Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives

Journal of Steroid Biochemistry and Molecular Biology

Volumn 59, Issue 1, 1996, Pages 83-91

  Selcer, Kyle W ^a   Jagannathan, Sharada ^a   Rhodes, Michael E ^a   Li, Pui Kai ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; ESTRONE DERIVATIVE; SULFATASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL GROWTH; CELL LINE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PLACENTA;

ADENOCARCINOMA; BREAST NEOPLASMS; CELL DIVISION; DANAZOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRADIOL CONGENERS; ESTROGENS; ESTRONE; FEMALE; HUMANS; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PLACENTA; SULFATASES; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030236696     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(96)00089-1     Document Type: Article

References (27)

1. 1. Henderson I. C. and Cannelles G. P.: Cancer of the breast: the past decade. N. Engl J. Med. 320 (1980) 17-30.
2. 2. Kirschner M. A.: The role of hormones in the development of human breast cancer. In Breast Cancer 3: Advances in Research and Treatment, Current Topics (Edited by McGuire W. L.). Plenum Press, New York (1979) pp. 199-226.
3. 3. Henderson B. E., Ross R. K., Pike M. C and Casagrande J. T.: Endogenous hormones as a major factor in human cancer. Cancer Res. 42 (1982) 3232-3269.
4. 4. Bonney R. C., Reed M. J., Davidson K., Berenek P. A. and James V. H. T.: The relationship between 17ß hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissues. Clin. Endocr. 19 (1983) 727-739.
5. 5. VanLandegham A. A. J., Poortman J., Nabuurs M. and Thijssen J. H. H.: Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 45 (1985) 2900-2906.
6. 6. Edery M., Goussard J., Dehennin L., Scholler R., Reiffsteck J. Drosdowsky M. A.: Endogenous oestradiol-17ß concentration in breast tumors determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur. J. Cancer 17 (1981) 115-120.
7. 7. Millington D. S.: Determination of hormonal steroid concentrations in biological extracts by high resolution fragmentography. J. Steroid Biochem. 6 (1975) 239-245.
8. 8. Siiteri P. K.: Review of studies of estrogen biosynthesis in the human. Cancer Res. 42 (1982) 3269-3273.
9. 9. Santen R. J., Leszczynski D, Tilson-Mallet N., Feil P. D., Wright C., Manni A. and Santner S. J.: Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann. N.Y. Acad. Sci. 464 (1986) 126-137.
10. 10. Dibbelt L. and Kuss E.: Human placental steryl-sulphatase. Biol. Chem. Hoppe-Seyler 367 (1986) 1223-1229.
11. 11. Purohit A., Dauvois S., Parker M. G., Potter B. V. L., Williams G. J. and Reed M. J.: The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in COS-1 cells. J. Steroid Biochem. Molec. Biol. 50 (1994) 101-104.
12. 12. Noel C. T., Reed M. J., Jacobs H. S. and James V. H. T.: The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J. Steroid Biochem. 14 (1981) 1101-1105.
13. 13. Samojlik E., Santen R. J. and Worgul T. J.: Plasma estrone sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma. Steroids 39 (1982) 497-507.
14. 14. Ruder H. J., Loriaux D. L. and Lipsett M. B.: Estrone sulphate: production rate and metabolism in man. J. Clin. Invest. 51 (1972) 1020-1023.
15. 15. Tilson-Mallet N., Santner S. J., Feil P. D. and Santen R. L: Biologic significance of aromatase activity in human breast tumors. J. Clin. Endocr. Metab. 57 (1983) 1125-1128.
16. 16. Santner S. J., Feil P. D. and Santen R. J.: In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway. J. Clin. Endocr. Metab. 59 (1984) 29-33.
17. 17. Duncan L., Purohit A., Howarth N. M., Potter B. V. L. and Reed M. J.: Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer. Cancer Res. 53 (1993) 298-303.
18. 18. Howarth N. M., Cooper G., Purohit A., Duncan L., Reed M. J. and Potter B. V. L.: Phosphonates and thiophosphonates as sulfate surrogates: synthesis of estrone-3-methylthiophosphonate, a potent inhibitor of estrone sulfatase. Bioorg. Med. Chem. Lett. 3 (1993) 313-318.
19. 19. Howarth N. M., Purohit A., Reed M. J. and Potter B. V. L.: Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J. Med. Chem. 37 (1994) 219-221.
20. 20. Li P. K., Pillai R., Young B. L., Bender W. H., Martino D. M. and Lin F. T.: Synthesis and biochemical studies of estrone sulfatase inhibitors. Steroids 58 (1993) 106-111.
21. 21. Dibbelt L., Li P. K., Pillai R. and Knuppen R.: Inhibition of human placental sterylsulfatase by synthetic analogs of estrone sulfate. J. Steroid Biochem. Molec. Biol. 52 (1995) 281-286.
22. 22. Li P. K., Pillai R. and Dibbelt L.: Estrone sulfate analogs as estrone sulfatase inhibitors. Steroids 60 (1995) 299-306.
23. 23. Reed M. J. and Purohit A.: Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev. Endocr.-related Cancer 45 (1993) 51-62.
24. 24. Conrow R. B. and Bernstein S.: Some fused diaza-heterocycles of estra-1,3,5(10)-triene-17-one. Steroids 2 (1968) 151.
25. 25. Nguyen B.-L., Ferme I., Chetrite G. and Pasqualini J. R.: Action of Danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D, and MDA-MB-231 human mammary cancer cells. J. Steroid Biochem. Molec. Biol. 46 (1993) 17-23.
26. 26. Purohit A. and Reed M. J.: Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast-cancer cells: modulation by steroidal and non-steroidal therapeutic agents. Int. J. Cancer 50 (1992) 901-905.
27. 27. Santner S. J., Ohlsson-Wilhelm B. and Santen R. L: Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures. Int. J. Cancer 54 (1993) 119-124.